# COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program

> **NCT04881214** · NA · UNKNOWN · sponsor: **University Hospital, Geneva** · enrollment: 60 (estimated)

## Conditions studied

- Covid19 Pneumonia
- Chronic Thromboembolic Pulmonary Hypertension
- Myopathy
- Restrictive Lung Disease

## Interventions

- **OTHER:** Pulmonary rehabilitation

## Key facts

- **NCT ID:** NCT04881214
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04881214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04881214, "COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04881214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*